WO2011112002A3 - Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient - Google Patents

Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient Download PDF

Info

Publication number
WO2011112002A3
WO2011112002A3 PCT/KR2011/001631 KR2011001631W WO2011112002A3 WO 2011112002 A3 WO2011112002 A3 WO 2011112002A3 KR 2011001631 W KR2011001631 W KR 2011001631W WO 2011112002 A3 WO2011112002 A3 WO 2011112002A3
Authority
WO
WIPO (PCT)
Prior art keywords
vaccinium uliginosum
macular degeneration
fractions
composition
treating
Prior art date
Application number
PCT/KR2011/001631
Other languages
French (fr)
Korean (ko)
Other versions
WO2011112002A2 (en
Inventor
정세영
Original Assignee
주식회사 호일바이오메드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 호일바이오메드 filed Critical 주식회사 호일바이오메드
Priority to JP2012556977A priority Critical patent/JP5860418B2/en
Priority to CN201180016617.7A priority patent/CN102821773B/en
Publication of WO2011112002A2 publication Critical patent/WO2011112002A2/en
Publication of WO2011112002A3 publication Critical patent/WO2011112002A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The present invention relates to a composition for treating, preventing or relieving macular degeneration, containing a Vaccinium uliginosum extract or Vaccinium uliginosum fractions as an active ingredient. The Vaccinium uliginosum extract and Vaccinium uliginosum fractions, which are active ingredients of the present invention, suppress the accumulation of A2E on retinal pigment epithelial cells and inhibit the oxidation of A2E to effectively protect retinal pigment epithelial cells, and thereby prevent the cause of macular degeneration. Therefore, the composition of the present invention can be developed into various products such as a pharmaceutical, a dietary supplement, and the like, for excellently treating or relieving macular degeneration.
PCT/KR2011/001631 2010-03-10 2011-03-09 Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient WO2011112002A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2012556977A JP5860418B2 (en) 2010-03-10 2011-03-09 A composition for treating, preventing or ameliorating macular degeneration comprising a blackberry extract or a blackberry fraction as an active ingredient
CN201180016617.7A CN102821773B (en) 2010-03-10 2011-03-09 Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0021449 2010-03-10
KR20100021449 2010-03-10

Publications (2)

Publication Number Publication Date
WO2011112002A2 WO2011112002A2 (en) 2011-09-15
WO2011112002A3 true WO2011112002A3 (en) 2012-01-12

Family

ID=44564001

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/001631 WO2011112002A2 (en) 2010-03-10 2011-03-09 Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient

Country Status (4)

Country Link
JP (1) JP5860418B2 (en)
KR (1) KR101330850B1 (en)
CN (1) CN102821773B (en)
WO (1) WO2011112002A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101484386B1 (en) * 2013-01-23 2015-01-19 정수영 A composition for treating macular degeneration, comprising a phenolic compound isolated from extract of Vaccinium Uliginosum as an active ingredient
KR20170036352A (en) 2015-09-24 2017-04-03 동아에스티 주식회사 A composition for treating macular degeneration comprising a extract of Vaccinium Uliginosum as an active ingredient
KR102481709B1 (en) 2015-12-21 2022-12-27 동아제약 주식회사 A composition for treating dry eye syndrome comprising a extract of Vaccinium Uliginosum as an active ingredient
KR20210142445A (en) 2020-05-18 2021-11-25 (주)비지엔케어 Retinal disease prevention and treatment composition comprising turmeric extract

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175720A1 (en) * 2002-04-03 2005-08-11 Mckenzie Maureen A. Vaccinium species compositions with novel beneficial properties
KR20060066866A (en) * 2004-12-14 2006-06-19 학교법인 한림대학교 Composition for inhibiting development of diabetes induced complication containing extracts from vaccinium uliginosum

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1032176A (en) * 1988-07-02 1989-04-05 黑龙江中医学院 The extraction process of pigment of vaccinium uliginosum
US5474774A (en) * 1994-03-25 1995-12-12 Jlb, Inc. Adhesion inhibiting composition
US7306815B2 (en) * 2000-08-31 2007-12-11 Phenolics, Llc Compositions enriched in phenolic compounds and methods for producing the same
US20080206175A1 (en) * 2005-01-11 2008-08-28 Se Young Chung Composition for Skin Whitening and Wrinkle Improvement Comprising Vaccinium Uliginosum Extract and Method for Preparation Thereof
JP4873904B2 (en) * 2005-08-22 2012-02-08 国立大学法人弘前大学 Ocular blood flow disorder improving agent
WO2007094193A1 (en) * 2006-02-15 2007-08-23 Wakasa Seikatsu Co., Ltd Anti-angiogenic agent, prophylactic or therapeutic agent for disease accompanied by angiogenesis, and food
CN101265252B (en) * 2008-04-28 2011-03-23 吉林市新科奇保健食品有限公司 Vaccinium uliginosum cyanidin and separation and purification method thereof
CN102258165B (en) * 2010-09-08 2012-10-03 李德海 Bog bilberry anthocyanin tablet and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175720A1 (en) * 2002-04-03 2005-08-11 Mckenzie Maureen A. Vaccinium species compositions with novel beneficial properties
KR20060066866A (en) * 2004-12-14 2006-06-19 학교법인 한림대학교 Composition for inhibiting development of diabetes induced complication containing extracts from vaccinium uliginosum

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YOUNG-HEE KIM ET AL.: "Antioxidant Activities of Vaccinium uliginosum L. Extract and Its Active Components", JOURNAL OF MEDICINAL FOOD, vol. 12, no. 4, 7 September 2009 (2009-09-07), pages 885 - 982 *

Also Published As

Publication number Publication date
JP5860418B2 (en) 2016-02-16
CN102821773A (en) 2012-12-12
CN102821773B (en) 2014-09-03
WO2011112002A2 (en) 2011-09-15
JP2013522188A (en) 2013-06-13
KR20110102246A (en) 2011-09-16
KR101330850B1 (en) 2013-11-18

Similar Documents

Publication Publication Date Title
WO2013027984A3 (en) Cosmetic composition containing green tea component
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
WO2012050396A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating liver cancer
WO2012157978A3 (en) Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis
WO2013178965A3 (en) Active ingredients activating mitophagy in skin cells and use of same for improving skin condition
PL2941263T3 (en) A purified extract isolated from pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
EP3279210A4 (en) Peptide having anticancer activity, and pharmaceutical composition and dietary supplement composition for preventing and treating cancer, both of which contain same as active ingredient
PH12017500706A1 (en) Composition containing extract or fraction of genus justicia plant
WO2010041832A3 (en) Antioxidant active composition containing an ishige okamurae-derived compound
WO2012070835A3 (en) Cosmetic composition containing gulfweed extract, sea staghorn extract, and brown seaweed extract
WO2011149301A3 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
WO2011112002A3 (en) Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient
WO2012050398A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating lung cancer
WO2012050397A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating kidney cancer
WO2013100718A3 (en) Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient
WO2016186349A3 (en) Composition, containing quisaqualis indica extract, for preventing or treating prostatic hyperplasia
WO2012134172A3 (en) Composition containing, as an active ingredient, an ethyl acetate fraction of schisandra chinensis baill, or wuweizisu c separated from the fraction, for preventing or treating obesity
WO2013170086A3 (en) Formulations for the delivery of active ingredients
EP3146976A4 (en) Pharmaceutical composition for preventing or treating diabetic complications and angioedema, containing natural mixture extract as active ingredient
WO2015000053A8 (en) Enzyme formulation for use as food supplement
WO2010009809A3 (en) Active substance combinations consisting of an anis fruit extract and hyaluronic acid
WO2013000895A9 (en) Dha and epa in the reduction of oxidative stress
WO2012108748A3 (en) Composition and cosmetic composition for treating brain cancer comprising albizzia julibrissin extract
WO2012036414A3 (en) Cosmetic composition comprising a fermented soybean extract fraction as an active ingredient
WO2011157955A3 (en) Chitosan powder

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180016617.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11753607

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012556977

Country of ref document: JP

122 Ep: pct application non-entry in european phase

Ref document number: 11753607

Country of ref document: EP

Kind code of ref document: A2